SG11201810261UA - Kidney disease prognosis prediction method and system - Google Patents
Kidney disease prognosis prediction method and systemInfo
- Publication number
- SG11201810261UA SG11201810261UA SG11201810261UA SG11201810261UA SG11201810261UA SG 11201810261U A SG11201810261U A SG 11201810261UA SG 11201810261U A SG11201810261U A SG 11201810261UA SG 11201810261U A SG11201810261U A SG 11201810261UA SG 11201810261U A SG11201810261U A SG 11201810261UA
- Authority
- SG
- Singapore
- Prior art keywords
- kidney disease
- prognosis
- prediction method
- prognosis prediction
- disease prognosis
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6806—Determination of free amino acids
- G01N33/6812—Assays for specific amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016099158 | 2016-05-17 | ||
PCT/JP2017/018591 WO2017200024A1 (ja) | 2016-05-17 | 2017-05-17 | 腎臓病の予後予測方法及びシステム |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201810261UA true SG11201810261UA (en) | 2018-12-28 |
Family
ID=60325935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201810261UA SG11201810261UA (en) | 2016-05-17 | 2017-05-17 | Kidney disease prognosis prediction method and system |
Country Status (8)
Country | Link |
---|---|
US (2) | US11099191B2 (zh) |
EP (1) | EP3460477A4 (zh) |
JP (1) | JP7123329B2 (zh) |
CN (1) | CN109154621B (zh) |
AU (1) | AU2017266330A1 (zh) |
IL (1) | IL263025A (zh) |
SG (1) | SG11201810261UA (zh) |
WO (1) | WO2017200024A1 (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111033637B (zh) * | 2017-08-08 | 2023-12-05 | 费森尤斯医疗保健控股公司 | 用于治疗和评估慢性肾脏疾病的进程的***和方法 |
TW202022379A (zh) * | 2018-10-17 | 2020-06-16 | 日商資生堂股份有限公司 | 檢定根據血液中之肌酸酐含量之腎功能檢查結果之妥當性之方法 |
JPWO2020080482A1 (ja) * | 2018-10-17 | 2021-09-09 | Kagami株式会社 | 血液中のシスタチンc量に基づく腎機能検査結果の妥当性を検定する方法 |
EP3869202A4 (en) * | 2018-10-17 | 2022-08-10 | Kagami Inc. | PROCEDURE FOR DETERMINING GLOMERULAR FILTRATION ABILITY |
WO2020196437A1 (ja) * | 2019-03-22 | 2020-10-01 | Kagami株式会社 | 腎病態の評価を補助する方法、腎病態の評価システム及び腎病態の評価プログラム |
US20220252610A1 (en) * | 2019-03-22 | 2022-08-11 | Kagami Inc. | Method for assisting evaluation of condition of kidneys, system for evaluating condition of kidneys, and program for evaluating condition of kidneys |
US20230037869A1 (en) * | 2019-12-27 | 2023-02-09 | Kagami Inc. | Method and system for estimating renal function |
CN114636774B (zh) * | 2022-04-22 | 2024-05-17 | 苏州市疾病预防控制中心 | 一种预测青少年高血压患病风险的生物代谢标志物组合物 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4378472B2 (ja) | 2001-12-27 | 2009-12-09 | 独立行政法人産業技術総合研究所 | 麹菌daoC遺伝子 |
EP1482310A1 (en) * | 2003-05-30 | 2004-12-01 | Bayer HealthCare AG | Relaxin as an independent risk factor predicting mortality |
WO2006060793A2 (en) * | 2004-12-01 | 2006-06-08 | Children's Hospital & Research Center At Oakland | Diagnosis of conditions associated with decreased arginine bioavailability |
US20070037232A1 (en) * | 2005-03-31 | 2007-02-15 | Barasch Jonathan M | Detection of NGAL in chronic renal disease |
TW201250248A (en) * | 2011-04-25 | 2012-12-16 | Kyowa Medex Co Ltd | Prognostication method of renal failure |
WO2013115283A1 (ja) * | 2012-01-31 | 2013-08-08 | 味の素株式会社 | 早期腎症の評価方法、早期腎症評価装置、早期腎症評価方法、早期腎症評価プログラム、早期腎症評価システムおよび情報通信端末装置 |
CN114966050A (zh) | 2012-03-18 | 2022-08-30 | 镜株式会社 | 疾病样品分析装置、分析***及分析方法 |
DK2904403T3 (en) * | 2012-10-02 | 2018-07-16 | Sphingotec Gmbh | PROCEDURE FOR DIAGNOSTICATION OR MONITORING OF Kidney Function or Diagnosis of Kidney Function |
EP3081939B1 (en) * | 2013-12-11 | 2021-02-17 | Kagami Inc. | Marker for early diagnosis of kidney failure |
-
2017
- 2017-05-17 SG SG11201810261UA patent/SG11201810261UA/en unknown
- 2017-05-17 US US16/302,226 patent/US11099191B2/en active Active
- 2017-05-17 CN CN201780029354.0A patent/CN109154621B/zh active Active
- 2017-05-17 JP JP2017098354A patent/JP7123329B2/ja active Active
- 2017-05-17 WO PCT/JP2017/018591 patent/WO2017200024A1/ja active Search and Examination
- 2017-05-17 AU AU2017266330A patent/AU2017266330A1/en not_active Abandoned
- 2017-05-17 EP EP17799448.0A patent/EP3460477A4/en not_active Withdrawn
-
2018
- 2018-11-14 IL IL263025A patent/IL263025A/en unknown
-
2021
- 2021-07-13 US US17/374,777 patent/US20220003774A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2017200024A1 (ja) | 2017-11-23 |
JP2017207489A (ja) | 2017-11-24 |
EP3460477A4 (en) | 2020-01-08 |
US20190317106A1 (en) | 2019-10-17 |
US11099191B2 (en) | 2021-08-24 |
JP7123329B2 (ja) | 2022-08-23 |
AU2017266330A8 (en) | 2019-01-03 |
CN109154621A (zh) | 2019-01-04 |
US20220003774A1 (en) | 2022-01-06 |
IL263025A (en) | 2018-12-31 |
EP3460477A1 (en) | 2019-03-27 |
CN109154621B (zh) | 2022-08-05 |
AU2017266330A1 (en) | 2018-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201810261UA (en) | Kidney disease prognosis prediction method and system | |
EA201000427A1 (ru) | Секвенирование нуклеиново-кислотных полимеров с использованием электронной микроскопии | |
SG10201903822XA (en) | Method for the enrichment of circulating tumor dna | |
WO2010062913A3 (en) | Methods and systems for analysis of sequencing data | |
EA200800909A1 (ru) | Получение прегабалина и родственных соединений | |
CA2867508C (en) | Immunofluorescence and fluorescent-based nucleic acid analysis on a single sample | |
EA201100300A1 (ru) | Композиции и способы, предназначенные для направленного воздействия антител на белок c5 системы комплемента | |
ATE512228T1 (de) | Induzierbare expressionssysteme | |
ATE483825T1 (de) | Zusammensetzungen für die identifizierung von adenoviren | |
EA201290546A1 (ru) | Устойчивые к гербицидам растения | |
ATE504836T1 (de) | Verfahren zur identifizierung von trpv2- modulatoren | |
MX2020010947A (es) | Metodos de tratamiento de enfermedad de alzheimer. | |
AU2017266331A8 (en) | Blood sample analysis method and system, for determining diabetes | |
EA201990599A1 (ru) | Способ и система для получения и секвенирования библиотеки на основе crispr | |
DK1866433T3 (da) | Fremgangsmåde til identifikation af LRRK-2interagerende molekyler og til rensning af LRRK2 | |
CA2839777C (en) | Methods for the prognostic and/or diagnostic of neurodegenerative disease, methods to identify candidate compounds and compounds for treating neurodegenerative disease | |
UA105296C2 (ru) | Определение и подсчет микроорганизмов | |
BR112022003546A2 (pt) | Método de isolar nucleossomos circulantes | |
SG154401A1 (en) | Method of processing genomic information | |
MX2019002929A (es) | Biomarcadores de arn para angioedema hereditario. | |
BR112019005167A2 (pt) | método e kit para analisar uma amostra | |
GB0509611D0 (en) | Method and device for imaging a sample | |
DE602004018155D1 (de) | Einen grössenausschlussschritt verwendendes verbessertes bisulfit-verfahren | |
FR3066071B1 (fr) | Dispositif pour la collecte et la restitution de molecules odorantes et methode de detection. | |
MX2020008348A (es) | Prediccion de perdida de embarazo. |